RECRUITING

Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed study aims to understand poor sleep as a possible cause to CAPD in children and adolescents with ASD (ASD+) compared to ASD youth without CAPD (ASD-), using both caregiver-report and objective clinician administered measures. Additionally, the study will aim to understand the complex relationship between CAPD, sleep, and other associated phenotypic features of ASD such as executive and psychiatric functioning.

Official Title

Contribution of Central Auditory Processing Disorder (CAPD) to Sleep Disturbances in Autism Spectrum Disorder (ASD)

Quick Facts

Study Start:2023-11-01
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06059352

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Have diagnosis of Autism Spectrum Disorder confirmed by the Autism Diagnostic Observation Schedule and the Social Communication Questionnaire, Lifetime Version which will be filled by the parent
  2. * IQ of 50 or higher on the Abbreviated Battery IQ Score
  1. * No confirmed diagnosis of Autism Spectrum Disorder
  2. * History of sleep apnea
  3. * History of restless leg syndrome
  4. * History of any neurological disorders (e.g., seizures, tumors, etc.)
  5. * Significant substance use in the past six months
  6. * Inpatient hospitalization in the past three months-period

Contacts and Locations

Study Contact

Fatimah Alramadhan, DrPH
CONTACT
9095584000
falramadhan@llu.edu

Principal Investigator

Aarti Nair, PhD
PRINCIPAL_INVESTIGATOR
Loma Linda University

Study Locations (Sites)

Loma Linda University Health
Loma Linda, California, 92350
United States

Collaborators and Investigators

Sponsor: Loma Linda University

  • Aarti Nair, PhD, PRINCIPAL_INVESTIGATOR, Loma Linda University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-01
Study Completion Date2025-11

Study Record Updates

Study Start Date2023-11-01
Study Completion Date2025-11

Terms related to this study

Additional Relevant MeSH Terms

  • Central Auditory Processing Disorder
  • Autism Spectrum Disorder
  • Sleep Disturbance